World Diabetes Day 2024
November 14, 2024 is the 18th United Nations Diabetes Day (WDD). WDD is led by the International Diabetes Federation (IDF) and each World Diabetes Day focuses on a theme related to diabetes. Type 2 diabetes is a largely preventable and treatable non-communicable disease that is rapidly increasing in numbers worldwide.
The Dangers of Diabetes
Diabetes may induce cerebral insufficiency, cerebral thrombosis, angina pectoris, cardiac insufficiency, myocardial infarction, and other hazards.
- Insufficient blood supply to the brain: Diabetes may be caused by bad eating habits. Once it causes vascular sclerosis, vascular stenosis and blockage will occur, thereby inducing insufficient blood supply to the brain.
- Cerebral thrombosis: Diabetes is a type of vascular disease. If blood sugar is high for a long time and the condition cannot be controlled in time, once plaques or platelets aggregate, blood viscosity will increase, inducing cerebral thrombosis.
- Angina pectoris: If blood sugar is not well controlled for a long time, resulting in large fluctuations in blood sugar, it will cause arteriosclerosis of the heart and blood vessels and induce angina pectoris.
- Insufficient blood supply to the heart: If diabetes is more serious and the disease is not controlled in time, blood lipids will be deposited in the blood vessels. Once the lumen is narrowed, it may induce insufficient blood supply to the heart.
- Myocardial infarction: If blood sugar cannot be controlled for a long time, osmotic diuresis may occur, resulting in increased blood viscosity and myocardial infarction.
Early and accurate diagnosis and treatment of diabetes can effectively control diabetes and prevent the occurrence of some complications, improving the happiness of diabetic patients. HbA1c reflects the blood sugar control of diabetic patients and is one of the important criteria for diabetic blood sugar testing.
Diabetes Risk Factors
- Those with a family history of diabetes and typical symptoms of "three mores and one less", i.e. polydipsia, polyuria, polyphagia, emaciation (weight loss), or blood sugar levels higher than normal;
- Those with obesity, fatty liver, hypertension, hyperlipidemia, hyperuricemia and other metabolic abnormalities;
- Those with positive urine sugar;
- Diabetic patients should be examined once a year;
- Follow-up of those with previous impaired glucose tolerance;
- Frequent hypoglycemia: such as palpitations, sweating, hunger, and collapse;
- Those who gain weight too fast during pregnancy and are suspected of gestational diabetes; those with a normal pregnancy of 24 to 28 weeks, and a history of spontaneous abortion, premature birth, stillbirth or macrosomia in previous pregnancies; those suspected of polycystic ovary syndrome.
Aehealth Diabetes Control Solution for Diabetic Blood Glucose Monitoring
- Laffinite II HPLC Hemoglobin Analyzer uses the "gold standard" method - ion exchange high performance liquid chromatography (HPLC), high throughput testing, accurate and reliable results, and can report both NGSP and IFCC units. Used in medium and large hospitals and laboratories.
- Fluorescence Immunoassay Analyzer is easy to operate, with a variety of models to choose from, which can be used in more outdoor places. Single-serve packaging does not waste reagents, and it can be transported and stored at room temperature. The results are accurate and suitable for small and medium-sized hospitals and laboratories.
